- Home
- HAS vs EXAS Comparison
HAS vs EXAS Comparison
Compare HAS & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAS
- EXAS
- Stock Information
- Founded
- HAS 1923
- EXAS 1995
- Country
- HAS United States
- EXAS United States
- Employees
- HAS N/A
- EXAS N/A
- Industry
- HAS Recreational Games/Products/Toys
- EXAS Medical Specialities
- Sector
- HAS Consumer Discretionary
- EXAS Health Care
- Exchange
- HAS Nasdaq
- EXAS Nasdaq
- Market Cap
- HAS 9.6B
- EXAS 10.7B
- IPO Year
- HAS N/A
- EXAS N/A
- Fundamental
- Price
- HAS $76.55
- EXAS $52.48
- Analyst Decision
- HAS Strong Buy
- EXAS Strong Buy
- Analyst Count
- HAS 10
- EXAS 20
- Target Price
- HAS $80.70
- EXAS $70.16
- AVG Volume (30 Days)
- HAS 2.4M
- EXAS 2.7M
- Earning Date
- HAS 07-23-2025
- EXAS 07-30-2025
- Dividend Yield
- HAS 3.66%
- EXAS N/A
- EPS Growth
- HAS N/A
- EXAS N/A
- EPS
- HAS 3.03
- EXAS N/A
- Revenue
- HAS $4,265,300,000.00
- EXAS $2,828,128,000.00
- Revenue This Year
- HAS $3.16
- EXAS $14.58
- Revenue Next Year
- HAS $4.15
- EXAS $12.75
- P/E Ratio
- HAS $25.27
- EXAS N/A
- Revenue Growth
- HAS N/A
- EXAS 11.57
- 52 Week Low
- HAS $49.00
- EXAS $39.97
- 52 Week High
- HAS $78.83
- EXAS $72.83
- Technical
- Relative Strength Index (RSI)
- HAS 69.27
- EXAS 45.78
- Support Level
- HAS $72.23
- EXAS $52.60
- Resistance Level
- HAS $78.38
- EXAS $55.09
- Average True Range (ATR)
- HAS 1.90
- EXAS 2.11
- MACD
- HAS 0.57
- EXAS -0.06
- Stochastic Oscillator
- HAS 80.55
- EXAS 32.69
About HAS Hasbro Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.